Actionable news
0
All posts from Actionable news
Actionable news in IBB: iShares NASDAQ Biotechnology Index Fund,

AHF to Appeal Gilead AIDS Drug Patent Case

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) today announced that it will appeal the dismissal of its federal lawsuit filed against Gilead Sciences Inc. and other defendants alleging drug patent manipulation and anti-trust claims regarding slightly different formulations of tenofovir, a key HIV/AIDS drug. Last week, Judge William Alsup of the U.S. District Court, Northern District of California, granted a Motion to Dismiss sought by Gilead in the case [Case # 3:16-cv-00443]; however, the Court’s order suggested that this case is ripe for reconsideration by higher courts.

"We intend to appeal this all the way to the Supreme Court, if necessary," Michael Weinstein, President, AHF

Tweet this

AHF’s case focuses on patents of certain Gilead drugs used in Fixed Dose Combinations (FDC), multiple drugs combined in one tablet or pill used in the treatment of people with HIV or AIDS. The drugs at the heart of AHF’s lawsuit are Gilead’s TAF (tenofovir alafenamide), which has fewer negative side effects than TDF (tenofovir disoproxil...


More